These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10281775)

  • 21. A new attitude: contracting for success with alternative delivery systems.
    Ross DJ; Hughes KE
    J Ambul Care Manage; 1987 Feb; 10(1):1-21. PubMed ID: 10301292
    [No Abstract]   [Full Text] [Related]  

  • 22. Alternative delivery systems are focus of antitrust scrutiny.
    Scammon DL; Fuller DA; Sheffet MJ
    J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715
    [No Abstract]   [Full Text] [Related]  

  • 23. Preferred provider organizations: an antitrust warning.
    Sandler AL
    Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861
    [No Abstract]   [Full Text] [Related]  

  • 24. Federal PPO legislation and health care competition.
    Ozga JP
    Health Cost Manage; 1984 Jan; 1(4):7-10. PubMed ID: 10280143
    [No Abstract]   [Full Text] [Related]  

  • 25. Ambulatory care and the law: HMO contracts.
    Goldsmith SB
    J Ambul Care Manage; 1988 Aug; 11(3):84-5. PubMed ID: 10288687
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacy participation in PPOs: an antitrust review.
    Health Matrix; 1984-1985 Winter; 2(4):35-7. PubMed ID: 10272758
    [No Abstract]   [Full Text] [Related]  

  • 27. Prepaid medical service plans; revocation of part.
    Fed Regist; 1978 May; 44(103):30341. PubMed ID: 10241575
    [No Abstract]   [Full Text] [Related]  

  • 28. PPOs: a challenge to HMOs?
    Kendrick M
    Group Health J; 1985; 6(2):22-7. PubMed ID: 10274981
    [No Abstract]   [Full Text] [Related]  

  • 29. Antitrust threat dissolves PPO.
    Cain C
    Bus Insur; 1984 Oct; 18(44):2, 18. PubMed ID: 10278278
    [No Abstract]   [Full Text] [Related]  

  • 30. The FTC and provider-controlled PPO price negotiations.
    Miles JJ
    Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716
    [No Abstract]   [Full Text] [Related]  

  • 31. Will the courts blow PPOs out of the water?
    Larson JL
    Physicians Manage; 1984 Nov; 24(11):149-52, 156, 159 passim. PubMed ID: 10269233
    [No Abstract]   [Full Text] [Related]  

  • 32. Will state governments push you out of practice?
    Anthony R
    Physicians Manage; 1986 May; 26(5):115-6, 119-20, 125-6. PubMed ID: 10300839
    [No Abstract]   [Full Text] [Related]  

  • 33. Contract analysis. A guide to participating provider agreements.
    Volland L; Shub J
    N Y State Dent J; 1996 May; 62(5):36-41. PubMed ID: 8692462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving market for preferred provider contracting.
    Boland P
    J Ambul Care Manage; 1987 May; 10(2):1-7. PubMed ID: 10281770
    [No Abstract]   [Full Text] [Related]  

  • 35. PPOs facing potential antitrust worries.
    Tarnoff S
    Bus Insur; 1985 Jul; 19(29):16, 20. PubMed ID: 10271746
    [No Abstract]   [Full Text] [Related]  

  • 36. Planning PPOs to minimize antitrust risk.
    Clanton DA
    Hospitals; 1985 Mar; 59(5):96, 98. PubMed ID: 3972373
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 38. Federal antitrust agencies send mixed signals to PPOs.
    Enders RJ
    Health Care Law Newsl; 1986 Jul; 1(1):12-4. PubMed ID: 10277502
    [No Abstract]   [Full Text] [Related]  

  • 39. FTC letter further confuses PPO price-fixing issue.
    Miles JJ
    Health Law Vigil; 1986 May; 9(9):5-7. PubMed ID: 10276714
    [No Abstract]   [Full Text] [Related]  

  • 40. More private, less government PPA antitrust action.
    Burda D
    Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.